课题基金 / 基金详情

Immune surveillance of antigen processing pathway

Immune surveillance of antigen processing pathway
抗原加工途径的免疫监视
批准号:
9287264
负责人:
Nilabh Shastri
金额:
$53.52万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-08 至 2022-02-28

项目摘要

项目成果

Nilabh Shastri的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 我们研究的长期目标是了解和操纵免疫监视途径。这个 抗原处理途径在细胞表面产生数以千计的多肽/MHC复合体(PMHC I) CD8+T细胞的潜在配体,使其能够检测病毒或癌症。现在很明显,这一代 正常的pMHC I谱系需要ERAAP对内质网(ER)中的多肽进行修剪 与抗原加工有关的氨基肽酶。ERAAP的目标是通过病毒进行免疫逃避 该基因的多态与许多自身免疫性疾病有关。因此,监测是至关重要的 ERAAP活性,以确保CD8+T细胞有效的免疫监视。 我们早些时候已经发现,独一无二的Fl9 NONA多肽源自于 未知功能-仅由非经典MHC Ib分子Qa-1b在ERAAP中提出- 缺乏细胞。这种被称为QFL的Fl9肽/Qa-1复合体被QFL特异性CD8+T细胞识别 裂解表达该配体的靶细胞。因此,QFL-T细胞是一种检测和消除细胞的机制 患有ERAAP缺乏症。QFL-T细胞相对丰富,并与其他 与生俱来的iNKT(不变NK T细胞)和MAIT(粘膜相关不变T细胞)细胞也受 非经典的MHC Ib分子,并对各种微生物和自身抗原产生反应。 在这里,我们建议填补我们对免疫系统如何监控保真度的理解的空白 急诊室的抗原处理。我们假设QFL特异性CD8+T细胞及其作用机制 产生QFL配体是检测ERAAP抑制的保守传感器。此外,中断 ERAAP缺陷小鼠的这些机制可能导致自身免疫性肥胖。 我们将通过(A)表征αβTCR和胸腺发育途径来实现这些目标 为了让QFL-T细胞了解这些细胞是如何产生的并获得其独特的功能,(B)定义 通过分析Fam49a/b前体进入QFL配体的过程来产生QFL配体的分子步骤 (C)确定QFL-T的解剖位置(S)和功能(S) 正常WT小鼠以及肥胖的ERAAP-/-小鼠体内的细胞。 相关性 当对自身抗原的免疫耐受性被破坏时,就会产生自身免疫。了解自身抗原是如何 是由蛋白水解酶产生的,可能会揭示干预自身免疫性疾病的潜在方法。
英文摘要
Project summary The long term goal of our research is to understand and manipulate immune surveillance pathways. The antigen processing pathway yields thousands of peptide/MHC complexes (pMHC I) on the cell surface as potential ligands for CD8+ T cells to allow detection of viruses or cancer. It is now clear that generation of the normal pMHC I repertoire requires peptide trimming in the endoplasmic reticulum (ER) by ERAAP, the ER aminopeptidase associated with antigen processing. The ERAAP is targeted for immune evasion by viruses and polymorphisms in this gene are linked to many autoimmune diseases. It is therefore essential to monitor ERAAP activity to ensure effective immune surveillance by CD8+ T cells. We had discovered earlier that the unique FL9 nona peptide — derived from the Fam49a/b proteins of unknown function — was presented by the non-classical MHC Ib molecule called Qa-1b only in ERAAP- deficient cells. This FL9 peptide/Qa-1 complex, called QFL was recognized by QFL-specific CD8+ T cells which lysed target cells expressing this ligand. Thus QFL- T cells are a mechanism for detecting and eliminating cells with ERAAP-deficiency. The QFL-T cells are relatively abundant, and share key characteristics with other innate-like iNKT (invariant NK T) and MAIT (mucosal - associated invariant T) cells which are also restricted by non-classical MHC Ib molecules and respond to various microbial and self-antigens. Here we propose to fill gaps in our understanding of how the immune system monitors the fidelity of antigen processing in the ER. We hypothesize that QFL-specific CD8+ T cells and the mechanisms for generating the QFL-ligand are conserved sensors for detecting ERAAP-inhibition. Furthermore, disruption of these mechanisms in ERAAP-deficient mice may result in autoimmune obesity. We will accomplish these goals by (a) characterizing the αβ TCRs and the thymic developmental pathway for QFL-T cells to understand how these cells arise and acquire their unique functions, (b) defining the molecular steps for generating the QFL-ligand by analyzing the processing of Fam49a/b precursors into the FL9 peptide for loading the Qa-1 MHC Ib, and (c) defining the anatomical location(s) and function(s) of QFL-T cells in normal WT mice as well as their obese ERAAP-/- counterparts. Relevance Autoimmunity results when immune tolerance to self-antigens is disrupted. Understanding how self-antigens are produced by proteolytic enzymes will likely reveal potential ways to intervene in autoimmune disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unconventional sources of peptides for antigen presentation
HLA-peptide repertoire in autoimmunity
Immune surveillance via non-classical MHC class Ib molecules
Immune surveillance via non-classical MHC class Ib molecules
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: